| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------|-------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | NeoGenomics Investor Presentation | | | | | | | | | | February 2021 | | | | | | | | | 1 and and and the see and 2 Forward-Looking Statements This presentation has been prepared by NeoGenomics, Inc. ("we," "us," "our," "NeoGenomics" or the "Company") and is made for informational purposes only and does not constitute an offer to se ...

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2020 Earnings Conference Call February 24, 2021 8:30 AM ET Company Participants Doug VanOort - Chairman, CEO Kathryn McKenzie - CFO Rob Shovlin - President, Clinical Division Bill Bonello - President, Informatics Division Doug Brown - Chief Strategy, CDO Charlie Eidson - Manager, IR Larry Weiss - CMO, Director of R&D George Cardoza - President, Pharma Services Division Lynn Tetrault - LID of Board of Directors Conference Call Participants Operator Good morning, ladies and g ...

NeoGenomics, Inc. (NASDAQ:NEO) Q3 2020 Results Earnings Conference Call October 27, 2020 8:30 AM ET Company Participants Doug VanOort - Chairman and CEO Kathryn McKenzie - Chief Financial Officer Rob Shovlin - President, Clinical Services Division George Cardoza - President, Pharma Services Division Bill Bonello - President, Informatics Division Doug Brown - Chief Strategy and Corporate Development Officer Charlie Eidson - Manager, Investor Relations Conference Call Participants Alex Nowak - Craig-Hallum Ca ...

< NF' NOMICS INVESTOR PRESENTATION August 2020 Forward-Looking Statements This presentation has been prepared by NeoGenomics, Inc. ("we," "us," "our," "NeoGenomics" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities ...

NeoGenomics, Inc. (NASDAQ:NEO) Q2 2020 Earnings Conference Call July 28, 2020 8:30 AM ET Company Participants Doug VanOort - Chief Executive Officer Kathryn McKenzie - Chief Financial Officer Rob Shovlin - President, Clinical Division Bill Bonello - President, Informatics Division and Director, Investor Relations George Cardoza - President, Pharma Services Division Larry Weiss - Chief Medical Officer Doug Brown - Chief Strategy and Corporate Development Officer Conference Call Participants Alex Nowak - Crai ...